Literature DB >> 29489726

Single-Leg Roman Chair Hold Is More Effective Than the Nordic Hamstring Curl in Improving Hamstring Strength-Endurance in Gaelic Footballers With Previous Hamstring Injury.

Ben Macdonald1, John OʼNeill2, Noel Pollock3, Bas Van Hooren4,5.   

Abstract

Macdonald, B, O'Neill, J, Pollock, N, and Van Hooren, B. Single-leg Roman chair hold is more effective than the Nordic hamstring curl in improving hamstring strength-endurance in Gaelic footballers with previous hamstring injury. J Strength Cond Res 33(12): 3302-3308, 2019-Poor hamstring strength-endurance is a risk factor for hamstring injuries. This study investigated the effectiveness of the single-leg Roman hold and Nordic hamstring curl in improving hamstring strength-endurance. Twelve Gaelic footballers (mean ± SD age, height, and mass were 25.17 ± 3.46 years, 179.25 ± 5.88 cm, 85.75 ± 4.75 kg, respectively) with a history of hamstring injury were randomized into 2 groups that performed 6 weeks of either Nordic hamstring curl or single-leg Roman chair hold training. The single-leg hamstring bridge (SLHB) was measured before and after intervention. The Roman chair group showed a very likely moderate magnitude improvement on SLHB performance for both legs (23.7% for the previously injured leg [90% confidence interval 9.6-39.6%] and 16.9% for the noninjured leg [6.2-28.8%]). The Nordic curl group showed a likely trivial change in SLHB performance for the noninjured leg (-2.1% [-6.7 to 2.6%]) and an unclear, but possibly trivial change for the previously injured leg (0.3% [-5.6 to 6.6%]). The Roman chair group improved very likely more with a moderate magnitude in both the noninjured (19.5% [8.0-32.2%]) and the previously injured leg (23.3% [8.5-40.0%]) compared with the Nordic curl group. This study demonstrated that 6-week single-leg Roman chair training substantially improved SLHB performance, suggesting that it may be an efficacious strategy to mitigate hamstring (re-) injury risk. Conversely, 6-week Nordic curl training did not substantially improve SLHB performance, suggesting this may not be the intervention of choice for modifying this risk factor.

Entities:  

Mesh:

Year:  2019        PMID: 29489726     DOI: 10.1519/JSC.0000000000002526

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  6 in total

Review 1.  Strength and Power Training in Rehabilitation: Underpinning Principles and Practical Strategies to Return Athletes to High Performance.

Authors:  Luca Maestroni; Paul Read; Chris Bishop; Anthony Turner
Journal:  Sports Med       Date:  2020-02       Impact factor: 11.136

2.  Single Leg Bridge Test is Not a Valid Clinical Tool to Assess Maximum Hamstring Strength.

Authors:  Gabriela Bissani Gasparin; João Breno Araujo Ribeiro-Alvares; Bruno Manfredini Baroni
Journal:  Int J Sports Phys Ther       Date:  2022-06-01

3.  Residual Force Enhancement Is Present in Consecutive Post-Stretch Isometric Contractions of the Hamstrings during a Training Simulation.

Authors:  Neil D Chapman; John W Whitting; Suzanne Broadbent; Zachary J Crowley-McHattan; Rudi Meir
Journal:  Int J Environ Res Public Health       Date:  2021-01-28       Impact factor: 3.390

4.  Muscle forces and fascicle behavior during three hamstring exercises.

Authors:  Bas Van Hooren; Benedicte Vanwanseele; Sam van Rossom; Panayiotis Teratsias; Paul Willems; Maarten Drost; Kenneth Meijer
Journal:  Scand J Med Sci Sports       Date:  2022-03-26       Impact factor: 4.645

Review 5.  Quo Vadis Nordic Hamstring Exercise-Related Research?-A Scoping Review Revealing the Need for Improved Methodology and Reporting.

Authors:  Tobias Alt; Jannik Severin; Marcus Schmidt
Journal:  Int J Environ Res Public Health       Date:  2022-09-07       Impact factor: 4.614

6.  Managing the return to sport of the elite footballer following semimembranosus reconstruction.

Authors:  Matt Taberner; Fares S Haddad; Andy Dunn; Adam Newall; Lloyd Parker; Esteban Betancur; Daniel D Cohen
Journal:  BMJ Open Sport Exerc Med       Date:  2020-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.